Navigation Links
Esperance Pharmaceuticals Announces Completion of Run-in Enrollment of Phase 2 Study of EP-100 Plus Paclitaxel in Advanced Ovarian Cancer
Date:8/28/2012

BATON ROUGE, La., Aug. 28, 2012 /PRNewswire/ -- Esperance Pharmaceuticals today announced the completion of the run-in cohort of its Phase 2, randomized, multi‐center trial of EP‑100 in combination with paclitaxel for patients with advanced ovarian cancer. EP‐100 is a targeted membrane‐disrupting peptide (tMDP) designed to seek and destroy cancer cells that over‐express luteinizing hormone releasing hormone (LHRH) receptors on their surfaces. LHRH receptors are over‐expressed in a wide range of cancers including ovarian cancer. In June, the Company presented results from the successful completion of a Phase 1 study of EP‑100 in advanced solid tumors at the American Society of Clinical Oncology (ASCO) Annual Meeting.

"We are pleased with the continued momentum behind EP‑100 and the progress of enrollment as we begin the randomized treatment phase," said Dr. Hector Alila, CEO of Esperance. "We are encouraged with early results, and look forward to accelerating enrollment in a very important, underserved patient population and providing an update on the clinical progress over time."

The randomized, Phase 2 trial of EP‑100 in combination with paclitaxel versus paclitaxel alone in patients with histologically confirmed epithelial ovarian carcinomas expressing LHRH‐receptors is actively enrolling patients in key clinical sites across the United States. Rationale for the study is based on the positive clinical evidence from escalating doses in 38 patients in the Phase 1 study and on preclinical studies showing synergies between EP‑100 and various chemotherapeutic agents.

About EP‑100

EP‑100, the lead candidate from Esperance's Cationic Lytic Peptide (CLYP™) platform technology, is a targeted membrane‐disrupting peptide (tMDP) designed to seek and destroy cancer cells that overexpress luteinizing hormone releasing hormone (LHRH) receptors on their s
'/>"/>

SOURCE Esperance Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Savient Pharmaceuticals to Present at the Rodman & Renshaw 14th Annual Healthcare Conference
2. Alder Biopharmaceuticals Receives $3.5 Million Milestone Payment from Bristol-Myers Squibb for Initiation of Phase 2 Clinical Trial of ALD518/BMS-945429 in Crohns Disease
3. Vanda Pharmaceuticals to Participate in Two September Healthcare Investor Conferences
4. AcelRx Pharmaceuticals to Present at Three Upcoming Investor Conferences
5. Actinium Pharmaceuticals Strengthens Management Team
6. Alexza Pharmaceuticals to Present at the Stifel Nicolaus 2012 Healthcare Conference
7. Imprimis Pharmaceuticals Signs Agreement With DPT Labs For Clinical Supplies In Advance Of Planned Phase 3 Studies For Its Ketoprofen-Based Topical Anti-Inflammatory Drug
8. Access Pharmaceuticals To Host Second Quarter Investor Call on Thursday, August 23, 2012
9. Lexicon Pharmaceuticals Reports Preliminary Results From Two Phase 1 Studies
10. Nouveau Life Pharmaceuticals (NOUV) Releases Calcium & Vitamin D for Strong Bones
11. Isis Pharmaceuticals Announces Redemption Of 2 5/8% Convertible Subordinated Notes Due 2027
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... 2014 BerGenBio AS, a biopharmaceutical ... resistant cancers, today announces that it has raised NOK90 ... new and existing investors. BerGenBio will use ... of its pipeline of innovative cancer therapeutics, in particular ... candidate, BGB324, a first-in-class selective Axl kinase inhibitor, which ...
(Date:12/15/2014)... and Washington State are not the ... Oregon , Alaska , and ... November 2014 elections. Photo - http://photos.prnewswire.com/prnh/20141212/164152 ... The benefits of legalizing cannabis are manifold. There are ... tax revenue for state and local governments, in addition to ...
(Date:12/15/2014)...   DaVita HealthCare Partners Inc.  (NYSE: ... and most innovative health care communities, today announced ... Clinical Research  (DCR) and  HealthCare Partners Clinical Research , ... clinical research and data analytics services, specifically in ... renal disease (ESRD), as well as primary care ...
Breaking Medicine Technology:BerGenBio Completes NOK90 Million Fundraising 2CannaInsider.com Estimates 200,000 New Jobs in the Cannabis Industry by 2015 2DaVita Clinical Research and HealthCare Partners Clinical Research to Merge and Expand Clinical Trials and Data Analytics Capabilities 2DaVita Clinical Research and HealthCare Partners Clinical Research to Merge and Expand Clinical Trials and Data Analytics Capabilities 3DaVita Clinical Research and HealthCare Partners Clinical Research to Merge and Expand Clinical Trials and Data Analytics Capabilities 4
... GAITHERSBURG, Md., June 27, 2011 /PRNewswire-USNewswire / -- ... new service for people with Acute Lymphoblastic Leukemia ... refund eligible patients 100 percent of any co-pay ... information on eligibility criteria, please call 1-800-490-3262, Monday ...
... of two studies testing drugs to slow or stop ... newly diagnosed with type 1 diabetes will be presented ... in San Diego and simultaneously published online in the ... National Institutes of Health,s international network of researchers, Type ...
Cached Medicine Technology:Financial Assistance Now Available for People with Acute Lymphoblastic Leukemia 2Financial Assistance Now Available for People with Acute Lymphoblastic Leukemia 3Financial Assistance Now Available for People with Acute Lymphoblastic Leukemia 4Two Studies Test Impact of Drugs to Slow Progression of Type 1 Diabetes 2Two Studies Test Impact of Drugs to Slow Progression of Type 1 Diabetes 3Two Studies Test Impact of Drugs to Slow Progression of Type 1 Diabetes 4
(Date:12/15/2014)... Street Dental Team ( http://www.MainStreetDentalTeam.com ), Unionville’s first full-time ... providing evidence on the impact of 100% pure fruit ... enough evidence already exists showing a negative link between ... the onset of tooth decay. One question that has ... fruit juice, meaning it is completely natural with no ...
(Date:12/15/2014)... OutMarket , a provider of ... Media Cheat Sheets ,” a guide that exposes the ... on the top ten social media networks. , ... awareness, engagement, and customer service. It can also increase ... impact on new networks and weather constantly changing algorithms, ...
(Date:12/15/2014)... -- Expert pilots process visual information more efficiently than ... decisions during landings, a new study shows. Landing ... to master, and 36 percent of all airplane crashes ... approach and landing. Researchers monitored the brain activity ... while they were at the controls of a flight ...
(Date:12/15/2014)... December 15, 2014 Emergo Group, Inc., ... 26 countries in North and South America, Europe, the ... from industry participants for its 2015 Medical Device Industry ... to identify upcoming business and market trends as well ... The survey targets areas including:, , ...
(Date:12/15/2014)... 15, 2014 Bacteroides is becoming the indicator ... it much more prevalent than coliforms, it cannot reproduce in ... environment. , Key Benefits of the new Bacteroides Sewage ... , Eliminates false positives from coliforms naturally occurring ... , Maintain the same sampling method with ...
Breaking Medicine News(10 mins):Health News:Main Street Dental Team, Unionville’s Most Innovative Dental Clinic, Comments on New Study Relating Pure Fruit Juice to Poor Oral Hygiene 2Health News:OutMarket Releases Cheat Sheets for Social Media Marketing 2Health News:OutMarket Releases Cheat Sheets for Social Media Marketing 3Health News:Study Shows Why Expert Pilots Are Experts 2Health News:Emergo’s Annual Survey Assessing the State of the Medical Device Industry Now Open 2
... Neurosurgeons from NYU Langone Medical Center will present research ... to treat neurosurgical conditions at the annual meeting of ... 14-18, 2012 in Miami Beach, FL. NYU Langone faculty ... at AANS, including: *Craino-Cervical and C1C2 Stabilization ...
... Virginia Commonwealth University School of Medicine researchers have discovered ... may contribute to high blood pressure and increase susceptibility to ... findings could provide clues to the best treatment approaches for ... can block blood flow to a pregnant woman,s internal organs ...
... Steven Reinberg HealthDay Reporter , THURSDAY, April ... called phthalates, which are found in soaps, lotions, plastics ... diabetes among older adults, Swedish researchers say. "Our ... contribute to the development of diabetes," said lead researcher ...
... , THURSDAY, April 12 (HealthDay News) -- Genetic evidence ... a new study says. The finding is significant because ... not, the researchers explained. The researchers compared the number ... life-cycle stage of head and body lice and found that ...
... in how exercise affects menopausal women, according to Penn ... one experiences more hot flashes after physical activity, while ... that seemed to differentiate the two groups was perceived ... of kinesiology. "These women have ways of dealing with ...
... Dotinga HealthDay Reporter , THURSDAY, April 12 (HealthDay ... stress, a new study from Denmark finds that the marriages ... likely to fall apart. The study debunks "a persistent ... one,s marriage and family. This is simply not true," said ...
Cached Medicine News:Health News:NYU Langone experts present research, clinical advances at neurosurgeons meeting 2Health News:Changes in gene expression may help explain high blood pressure in pregnancy 2Health News:Common Plastics Chemical Might Boost Diabetes Risk 2Health News:Common Plastics Chemical Might Boost Diabetes Risk 3Health News:Exercise and attitude may be thermostat for hot flashes 2Health News:Parents of Kids With Cancer No More Likely to Break Up 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: